- Home
- NVX vs VNDA Comparison
NVX vs VNDA Comparison
Compare NVX & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- VNDA
- Stock Information
- Founded
- NVX 2012
- VNDA 2002
- Country
- NVX Australia
- VNDA United States
- Employees
- NVX N/A
- VNDA N/A
- Industry
- NVX Industrial Machinery/Components
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- NVX Miscellaneous
- VNDA Health Care
- Exchange
- NVX Nasdaq
- VNDA Nasdaq
- Market Cap
- NVX 254.2M
- VNDA 270.0M
- IPO Year
- NVX N/A
- VNDA 2006
- Fundamental
- Price
- NVX $1.66
- VNDA $4.77
- Analyst Decision
- NVX Strong Buy
- VNDA Strong Buy
- Analyst Count
- NVX 1
- VNDA 2
- Target Price
- NVX $4.00
- VNDA $15.50
- AVG Volume (30 Days)
- NVX 314.2K
- VNDA 704.2K
- Earning Date
- NVX 01-01-0001
- VNDA 02-05-2025
- Dividend Yield
- NVX N/A
- VNDA N/A
- EPS Growth
- NVX N/A
- VNDA N/A
- EPS
- NVX N/A
- VNDA N/A
- Revenue
- NVX $6,875,112.00
- VNDA $190,858,000.00
- Revenue This Year
- NVX $89.31
- VNDA $5.60
- Revenue Next Year
- NVX $410.89
- VNDA $42.85
- P/E Ratio
- NVX N/A
- VNDA N/A
- Revenue Growth
- NVX 19.05
- VNDA N/A
- 52 Week Low
- NVX $1.40
- VNDA $3.46
- 52 Week High
- NVX $3.10
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- NVX 40.10
- VNDA 42.69
- Support Level
- NVX $1.50
- VNDA $4.49
- Resistance Level
- NVX $1.88
- VNDA $4.81
- Average True Range (ATR)
- NVX 0.11
- VNDA 0.18
- MACD
- NVX -0.02
- VNDA -0.03
- Stochastic Oscillator
- NVX 21.28
- VNDA 25.71
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration and Mining, Battery Technology, and NOVONIX Anode Materials. Graphite Exploration and Mining segment is engaged in the exploration and development of high-grade flake graphite deposits. The NOVONIX Anode Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Technology segment generates maximum revenue for the company.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.